期刊文献+

血清Betatrophin水平与冠状动脉粥样硬化性心脏病的关系 被引量:8

下载PDF
导出
摘要 目的探讨血清Betatrophin水平与冠状动脉粥样硬化性心脏病(冠心病)的关系。方法选择因胸痛行选择性冠状动脉造影患者348例,根据冠状动脉造影结果分为冠心病组186例、对照组162例。采用全自动生化分析仪检测两组血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDLC)、空腹血糖(FPG)。用酶联免疫吸附试验测定血清空腹胰岛素(FINS)、Betatrophin水平。结果与对照组比较,冠心病组血清TG、LDL-C、FINS、Betatrophin水平及HOMA-IR增高,差异有统计学意义(P均<0.05)。Spearman相关分析显示,冠心病患者Betrophin水平与年龄、BMI、TG、TC呈正相关(r分别为0.213、0.238、0.410、0.138,P均<0.05),与HOMA-IR呈负相关(r=-0.170,P<0.05)。以血清Betatrophin水平为因变量,年龄、BMI、TG、TC、LDL-C、HDL-C、HOMA-IR为自变量进行多重线性回归分析,显示LDL、TG、HOMA-IR是冠心病患者血清Betatrophin水平升高的独立相关因素(β分别为0.294、0.412、-0.351,P均<0.05)。结论血清Betatrophin水平与冠心病密切相关,且其水平变化受血脂和胰岛素抵抗等冠心病传统危险因素的影响。
出处 《山东医药》 CAS 北大核心 2016年第5期53-54,共2页 Shandong Medical Journal
  • 相关文献

参考文献13

  • 1Yi P, Park JS, Melton DA. Betatrophin:a hormone that controls pan- creatic beta cell prohferationE J ]. Cell , 2013,53(4 ):747-758.
  • 2Hu H, Sun W, Yu S, et al. Increased circulating levels of betatro- phin in newly diagnosed type 2 diabetic patients [ J ]. Diabetes Care, 2014,37 (10) :2718-2722.
  • 3Espes D, Martinell M, Carlsson PO. Increased circulating Betatro- phin concentrations in patients with type2 diabetic patients [ J ]. Int J Endoerinol, 2014(2014) :323407.
  • 4Refi G, Kim JY, Smas CM. Identification of TIFL, a novel adipo- cyte-enrlched insulin target gene with a role in lipid metabolism [ J ]. Am J Physiol Endocrinol Metab, 2012,303 ( 3 ) :334-351.
  • 5无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393. 被引量:2275
  • 6侯保俊,胡勇.中青年冠心病的临床及流行病学研究[J].中华高血压杂志,2015,23(3):111.
  • 7王韵阳,张迪,董静,蒋正尧,鲁晓晴,王颜刚.初诊2型糖尿病患者血清betatrophin水平及其与胰岛素抵抗水平的关系[J].中国现代医生,2015,53(3):4-6. 被引量:7
  • 8谢心苗,高婷,杨梅丽,陈培红,金华,杨莉丽,于雪梅.糖耐量正常人群而非2型糖尿病患者血清Betatrophin水平与Irisin相关[J].上海医学,2014,37(11):931-934. 被引量:4
  • 9Mattijssen F, Kersten S. Rugulation of triglyceride metabolism by Angiopoietiulike proteins[ J ]. Biochim Biophys Acta, 2012,1821 (5) :782-789.
  • 10Fu Z, Berhance F, Fite A, et al. Elevated circulating lipasin/Be- tatrophin in human type 2 diabetes and obesity[J]. Sci Rep, 2014 (4) :5013.

二级参考文献42

  • 1Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 2Eckel RH, Grundy SM, Zimmet PZ. The metabolic syn- drome[J]. The Lancet, 2005,365 (9468) : 1415-1428.
  • 3WANG C ,HOU X, BAO Y,et al. The metabolic syndrome increased risk of cardiovascular events in Chinese-A com- munity based study[J]. International Journal of Cardiology, 2010,139(2) : 159-165.
  • 4Zhang R. Lipasin, a novel nutritionally-regulated liver-en- riched factor that regulates serum triglyceride levels [J]. Biochemical and Biophysical Research Communications, 2012,424(4) : 786-792.
  • 5Fu Z, Yao F,Abou-samra AB,et al. Lipasin,thermoregu- lated in brown fat,is a novel but atypical member of the angiopoietin-like protein family[J]. Biochemical and Bio- physical Research Communications, 2013,430 (3) : 1126- 1131.
  • 6Ren G,Kim JY,Smas CM. Identification of RIFL,a novel adipocyte-enriched insulin target gene with a role in lipid metabolism[J]. American Journal of Physiology-Endocrinol- ogy and Metabolism, 2012,303 (3) : E334-E351.
  • 7Quagliarini F,Wang , Kozlitina J, et al. Atypical angiopoi- etin-like protein that regulates ANGIFL3[J]. Proceedings of the National Academy of Sciences,2012,109 (48) : 19751-19756.
  • 8Wang Y, Quagliarini F, Gusarova V, et al. Mice lackingANGPTL8 ( Betatrophin ) manifest disrupted triglyceride metabolism without impaired glucose homeostasis[J]. Pro- ceedings of the National Academy of Sciences,2013,110 (40) : 16109-16114.
  • 9Yi P, Park J-S, MeltonDA. Betatrophin : a hormone that controls pancreatic 13 cell proliferation[J]. Cell ,2013,153 (4) :747-758.
  • 10Tang T, Li L,Tang J, et al. A mouse knockout library for secreted and transmembrane proteins[J]. Nature Biotech- nology, 2010,28 (7) : 749-755.

共引文献2282

同被引文献61

  • 1陈宋明,李玉光,王东明,卢成志.冠心病患者外周血白细胞血红素氧合酶1的表达与冠状动脉病变程度有关[J].中国动脉硬化杂志,2004,12(5):581-584. 被引量:8
  • 2De Vita A,Milo M,Sestito A,et al.Association of coronary microvascular dysfunction with restenosis of left anterior descending coronary artery disease treated by percutaneous intervention[J].Int J Cardiol,2016,14(219):322-325.
  • 3Kim M,Park JH,Lee JH,et al.Comparison of long-term clinical outcomes of percutaneous coronary intervention in vasospastic angina patients associated with significant coronary artery stenosis[J].Int J Cardiol,2016,218:75-78.
  • 4Xiao-Dong Z,Fei-Fei L,Zhan-Peng W,et al.Renin-angiotensin system inhibitors in patients with coronary artery disease who have undergone percutaneous coronary intervention[J].TherAdvCardiovasc Dis,2016,10(3):172-177.
  • 5Ichikawa N,Toma N,Kawakita F,et al.AngiotensinⅡtype 1receptor blockers suppress neointimal hyperplasia after stent implantation in carotid arteries of hypercholesterolemic rabbits[J].Neurol Res,2015,37(2):147-152.
  • 6Safian RD.Restenosis after PCI:Battered but not beaten[J].Catheter Cardiovasc Interv,2016,87(2):209-210.
  • 7Suzuki N,Kozuma K,Kyono H,et al.The clinical characteristics and prognosis of lesions with in-stent eccentric tissue proliferation and strong signal attenuation detected by optical coherence tomography[J].Cardiovasc Interv Ther,2016,31(3):210-217.
  • 8Tian M,Sheng L,Huang P,et al.Agonistic autoantibodies against the angiotensin AT1receptor increase in unstable angina patients after stent implantation[J].Coron Artery Dis,2014,25(8):691-697.
  • 9Molnar P,Perrault R,Louis S,et al.The cyclic AMP response element-binding protein(CREB)mediates smooth muscle cell proliferation in response to angiotensinⅡ[J].J Cell Commun Signal,2014,8(1):29-37.
  • 10Wang S,Dougherty EJ,Danner RL.PPARγsignaling and emerging opportunities for improved therapeutics[J].Pharmacol Res,2016,4(111):76-85.

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部